Articles with "bevacizumab combined" as a keyword



Photo by nci from unsplash

Bevacizumab combined with capecitabine and oxaliplatin in patients with advanced adenocarcinoma of the small bowel or ampulla of vater: A single‐center, open‐label, phase 2 study

Sign Up to like & get
recommendations!
Published in 2017 at "Cancer"

DOI: 10.1002/cncr.30445

Abstract: Capecitabine with oxaliplatin (CAPOX) has previously demonstrated clinical activity in patients with small bowel adenocarcinoma (SBA) and ampullary adenocarcinoma (AAC). Herein, the authors conducted a phase 2 trial to evaluate the benefit of adding bevacizumab… read more here.

Keywords: small bowel; capecitabine oxaliplatin; oxaliplatin patients; bevacizumab combined ... See more keywords
Photo by freestocks from unsplash

Bevacizumab combined with chemotherapy for ovarian cancer

Sign Up to like & get
recommendations!
Published in 2021 at "Medicine"

DOI: 10.1097/md.0000000000028376

Abstract: Abstract Background: The impact of bevacizumab (an anti-vascular endothelial growth factor therapy) remains uncertain, which has been the focus of studies on the management of ovarian cancer (OC). We performed a protocol for systematic review… read more here.

Keywords: medicine; bevacizumab combined; bevacizumab; ovarian cancer ... See more keywords
Photo by kangterbang from unsplash

Efficacy and safety analysis of bevacizumab combined with capecitabine in the maintenance treatment of RAS‐mutant metastatic colorectal cancer

Sign Up to like & get
recommendations!
Published in 2022 at "Journal of Clinical Pharmacy and Therapeutics"

DOI: 10.1111/jcpt.13576

Abstract: The optimal strategy for maintenance therapy in patients with metastatic colorectal cancer (mCRC) remains controversial. Considering that, beyond progression, co‐therapy with bevacizumab and cytotoxic chemotherapy showed less toxicity and a significant disease control rate. We… read more here.

Keywords: bevacizumab combined; maintenance; metastatic colorectal; bevacizumab ... See more keywords
Photo from wikipedia

The Meta-Analysis of Bevacizumab Combined with Platinum-Based Treatment of Malignant Pleural Effusions by Thoracic Perfusion

Sign Up to like & get
recommendations!
Published in 2022 at "Journal of Oncology"

DOI: 10.1155/2022/1476038

Abstract: Objective To evaluate the safety of bevacizumab combined with platinum-based thoracic perfusion for treating lung cancer-related malignant pleural effusion (MPE) through meta-analysis. Methods The CNKI, PubMed, Cochrane Library, Embase, Chinese Science and Technology Journal Database… read more here.

Keywords: meta analysis; bevacizumab combined; combined platinum; thoracic perfusion ... See more keywords
Photo from wikipedia

Bevacizumab Combined with Intensity-Modulated Radiation Therapy on Cognitive and Coagulation Function in Postoperative Glioma Patients

Sign Up to like & get
recommendations!
Published in 2022 at "Journal of Healthcare Engineering"

DOI: 10.1155/2022/9367919

Abstract: To examine the influences of bevacizumab combined with intensity-modulated radiation therapy (IMRT) on postoperative brain glioma, particularly its impact on coagulation function and cognitive function, the complete clinical data of 156 patients undergoing glioma surgery… read more here.

Keywords: function; coagulation function; bevacizumab combined; group ... See more keywords
Photo by cedrikwesche from unsplash

Efficacy Evaluation of Bevacizumab Combined with Capecitabine in the Treatment of HER2-Negative Metastatic Breast Cancer: A Meta-Analysis

Sign Up to like & get
recommendations!
Published in 2023 at "Journal of Oncology"

DOI: 10.1155/2023/8740221

Abstract: Objective This study aims to evaluate the efficacy of bevacizumab combined with capecitabine in treating HER2-negative metastatic breast cancer through meta-analysis. Methods We searched literature from databases, including PubMed, Web of Science, Wiley Online Library,… read more here.

Keywords: her2 negative; bevacizumab combined; negative metastatic; group ... See more keywords
Photo by nampoh from unsplash

Efficacy and Safety of Bevacizumab Combined with Mitomycin C or 5-Fluorouracil in Primary Trabeculectomy: A Meta-Analysis of Randomized Clinical Trials

Sign Up to like & get
recommendations!
Published in 2018 at "Ophthalmic Research"

DOI: 10.1159/000486576

Abstract: Aim: The objective of this study was to evaluate the efficacy and safety of bevacizumab combined with antimetabolite as an adjunctive therapy in primary trabeculectomy for glaucoma. Materials and Methods: PubMed, Cochrane Library, and EMBASE… read more here.

Keywords: bevacizumab; efficacy safety; safety; bevacizumab combined ... See more keywords